157 related articles for article (PubMed ID: 31190154)
41. Effectiveness of fosfomycin-based antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy: A Korean multicenter study.
Lim DG; Jung SI; Hwang EC; Kim TH; Bae S; Huh JS; Lee SJ; Chung H; Choi H
Investig Clin Urol; 2023 May; 64(3):289-295. PubMed ID: 37341009
[TBL] [Abstract][Full Text] [Related]
42. Prospective assessment of the efficacy of single dose versus traditional 3-day antimicrobial prophylaxis in 12-core transrectal prostate biopsy.
Cam K; Kayikci A; Akman Y; Erol A
Int J Urol; 2008 Oct; 15(11):997-1001. PubMed ID: 18721198
[TBL] [Abstract][Full Text] [Related]
43. Rectal culture-directed antibiotic prophylaxis before transrectal prostate biopsy: Reduced infectious complications and healthcare costs.
Baldissera-Aradas JV; Rodríguez-Villamil L; Blanco-Fernández R; Pérez-García C; Viejo de la Guerra G; González-Rodríguez I; Mosquera-Madera J
Actas Urol Esp (Engl Ed); 2018 Sep; 42(7):465-472. PubMed ID: 29331324
[TBL] [Abstract][Full Text] [Related]
44. Comparison of guideline recommendations for antimicrobial prophylaxis in urologic procedures: variability, lack of consensus, and contradictions.
Ivan SJ; Sindhwani P
Int Urol Nephrol; 2018 Nov; 50(11):1923-1937. PubMed ID: 30145652
[TBL] [Abstract][Full Text] [Related]
45. Bisacodyl rectal preparation can decrease infectious complications of transrectal ultrasound-guided prostate biopsy.
Jeon SS; Woo SH; Hyun JH; Choi HY; Chai SE
Urology; 2003 Sep; 62(3):461-6. PubMed ID: 12946747
[TBL] [Abstract][Full Text] [Related]
46. Risk factors for and prophylactic effect of povidone-iodine rectal cleansing on infectious complications after prostate biopsy: a retrospective cohort study.
Hwang EC; Jung SI; Seo YH; Jeong SH; Kwon DD; Park K; Kim JW
Int Urol Nephrol; 2015 Apr; 47(4):595-601. PubMed ID: 25712677
[TBL] [Abstract][Full Text] [Related]
47. [Investigation of infection risk and the value of antibiotic prophylaxis during transrectal biopsy of the prostate by endotoxin determination].
Wang H; Zhou X; Chen S; Zhu C; Yu X
Zhonghua Nan Ke Xue; 2004 Jul; 10(7):496-8, 502. PubMed ID: 15354517
[TBL] [Abstract][Full Text] [Related]
48. The effectiveness of targeted relative to empiric prophylaxis on infectious complications after transrectal ultrasound-guided prostate biopsy: a meta-analysis.
Scott S; Harris PN; Williamson DA; Liss MA; Doi SAR; Roberts MJ
World J Urol; 2018 Jul; 36(7):1007-1017. PubMed ID: 29453690
[TBL] [Abstract][Full Text] [Related]
49. A prospective randomized comparative study of targeted versus empirical prophylactic antibiotics in the prevention of infective complications following transrectal ultrasound-guided prostate biopsy.
Doherty AF; Ikuerowo SO; Jeje EA; Ibrahim NA; Ojongbede OL; Mutiu WB; Omisanjo OA; Abolarinwa AA
Ann Afr Med; 2019; 18(3):132-137. PubMed ID: 31417013
[TBL] [Abstract][Full Text] [Related]
50. An antimicrobial prophylaxis protocol using rectal swab cultures for transrectal prostate biopsy.
Summers SJ; Patel DP; Hamilton BD; Presson AP; Fisher MA; Lowrance WT; Southwick AW
World J Urol; 2015 Dec; 33(12):2001-7. PubMed ID: 25935330
[TBL] [Abstract][Full Text] [Related]
51. Predictors of Infectious Complications after Targeted Prophylaxis for Prostate Needle Biopsy.
Papagiannopoulos D; Abern M; Wilson N; O'Block N; Raff L; Coogan C; Latchamsetty KC
J Urol; 2018 Jan; 199(1):155-160. PubMed ID: 28807644
[TBL] [Abstract][Full Text] [Related]
52. Highly effective prophylaxis with ertapenem for transrectal ultrasound-guided prostate biopsy: effects on overall antibiotic use and inpatient hospital exposure.
Bloomfield MG; Wilson AD; Studd RC; Blackmore TK
J Hosp Infect; 2020 Nov; 106(3):483-489. PubMed ID: 32861740
[TBL] [Abstract][Full Text] [Related]
53. The role of targeted prophylactic antimicrobial therapy before transrectal ultrasonography-guided prostate biopsy in reducing infection rates: a systematic review.
Cussans A; Somani BK; Basarab A; Dudderidge TJ
BJU Int; 2016 May; 117(5):725-31. PubMed ID: 26709240
[TBL] [Abstract][Full Text] [Related]
54. [Descriptive analysis of adverse events associated with transrectal prostatic biopsy after 603 procedures].
Santos Arrontes D; Luján Galán M; Pascual Mateo C; Chiva Robles V; Fernández González I; Berenguer Sánchez A
Arch Esp Urol; 2004; 57(6):601-5. PubMed ID: 15382435
[TBL] [Abstract][Full Text] [Related]
55. Assessment of antimicrobiral prophylaxis in transperineal prostate biopsy: A single-center retrospective study of 485 cases.
Baba K; Sekine Y; Miyazawa Y; Syuto T; Nomura M; Koike H; Matsui H; Shibata Y; Ito K; Suzuki K
J Infect Chemother; 2018 Aug; 24(8):637-640. PubMed ID: 29685852
[TBL] [Abstract][Full Text] [Related]
56. Single-dose oral ciprofloxacin versus placebo for prophylaxis during transrectal prostate biopsy.
Kapoor DA; Klimberg IW; Malek GH; Wegenke JD; Cox CE; Patterson AL; Graham E; Echols RM; Whalen E; Kowalsky SF
Urology; 1998 Oct; 52(4):552-8. PubMed ID: 9763070
[TBL] [Abstract][Full Text] [Related]
57. Peri-procedural povidone-iodine rectal preparation reduces microorganism counts and infectious complications following ultrasound-guided needle biopsy of the prostate.
Gyorfi JR; Otteni C; Brown K; Patel A; Lehman K; Phillips BE; Dewan K; Kirimanjeswara G; Raman JD
World J Urol; 2014 Aug; 32(4):905-9. PubMed ID: 24682238
[TBL] [Abstract][Full Text] [Related]
58. Antibiotic prophylaxis for transrectal needle biopsy of the prostate: a randomized controlled study.
Aron M; Rajeev TP; Gupta NP
BJU Int; 2000 Apr; 85(6):682-5. PubMed ID: 10759665
[TBL] [Abstract][Full Text] [Related]
59. Ciprofloxacin resistance in the faecal carriage of patients undergoing transrectal ultrasound guided prostate biopsy.
Taylor S; Margolick J; Abughosh Z; Goldenberg SL; Lange D; Bowie WR; Bell R; Roscoe D; Machan L; Black P
BJU Int; 2013 May; 111(6):946-53. PubMed ID: 23464844
[TBL] [Abstract][Full Text] [Related]
60. Antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy: fosfomycin trometamol, an attractive alternative.
Cai T; Gallelli L; Cocci A; Tiscione D; Verze P; Lanciotti M; Vanacore D; Rizzo M; Gacci M; Saleh O; Malossini G; Liguori G; Trombetta C; Rocco D; Palmieri A; Bartoletti R; Carini M; Wagenlehner FM; Naber K; Mirone V; Bjerklund Johansen TE
World J Urol; 2017 Feb; 35(2):221-228. PubMed ID: 27246847
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
